Abbott gets FDA clearance for over-the-counter continuous glucose monitors
Briefly

CGMs measure interstitial fluid glucose, handy for those seeking metabolic insights. Abbott offers Lingo for health-conscious users and Libre Rio for non-insulin-dependent Type 2 diabetics.
Lingo, a consumer wearable, provides glucose insights without diagnosing metabolic disorders. Libre Rio focuses on Type 2 diabetics managing through lifestyle changes, monitoring glucose from 40 to 400 mg/dL.
Read at The Verge
[
]
[
|
]